By Mill Chart
Last update: Dec 12, 2023
Growth investors are on the lookout for stocks displaying robust revenue and EPS growth. In this analysis, we'll assess whether DEXCOM INC (NASDAQ:DXCM) aligns with growth investing criteria, especially as it consolidates and signals a possible breakout. As always, investors should conduct their own research, but DEXCOM INC has surfaced on our radar for growth with base formation, warranting further examination.
Every stock receives a Growth Rating from ChartMill, ranging from 0 to 10. This rating assesses various growth aspects, including historical and projected EPS and revenue growth. NASDAQ:DXCM boasts a 9 out of 10:
To gauge a stock's financial health, ChartMill utilizes a Health Rating on a scale of 0 to 10. This comprehensive evaluation encompasses liquidity and solvency, both in absolute terms and in comparison to industry peers. NASDAQ:DXCM has earned a 6 out of 10:
ChartMill assigns a Profitability Rating to every stock. This score ranges from 0 to 10 and evaluates the different profitability ratios and margins, both absolutely, but also relative to the industry peers. NASDAQ:DXCM scores a 8 out of 10:
Besides the Technical Rating, ChartMill assigns a Setup Rating to every stock to determine the degree of consolidation. This rating, ranging from 0 to 10, is updated daily and evaluates various short-term technical indicators. NASDAQ:DXCM currently holds a 7 as its setup rating, suggesting a particular level of consolidation in the stock.
Besides having an excellent technical rating, DXCM also presents a decent setup pattern. We see reduced volatility while prices have been consolidating in the most recent period. A pullback is taking place, which may present a nice opportunity for an entry. There is a resistance zone just above the current price starting at 117.91. Right above this resistance zone may be a good entry point. There is a support zone below the current price at 117.89, a Stop Loss order could be placed below this zone.
More Strong Growth stocks can be found in our Strong Growth screener.
Our latest full fundamental report of DXCM contains the most current fundamental analsysis.
Our latest full technical report of DXCM contains the most current technical analsysis.
This is not investing advice! The article highlights some of the observations at the time of writing, but you should always make your own analysis and invest based on your own insights.
DEXCOM INC
NASDAQ:DXCM (4/24/2024, 2:20:06 PM)
137.26
+3.26 (+2.43%)
ResMed stock reversed higher Thursday after an analyst suggested weight-loss drugs could drive CPAP use.
Leverage Oprah's shift to prescription weight solutions with Weight-Loss ETFs, targeting companies leading in obesity treatment.
This April, discover three game-changing tech stocks with disruptive technologies poised to future-proof your portfolio in 2024.
Continuous glucose monitors have spiked in popularity since the advent of weight-loss drugs. Is chronic disease at its end?
Exploring the Growth Potential of DEXCOM INC (NASDAQ:DXCM) as It Nears a Breakout.
DoorDash, DexCom, and Advanced Micro Devices are three Nasdaq stocks to sell before reality sets in as exuberance may be fading.
Discover top obesity drug stocks set to soar as demand surges. Eli Lilly, Novo Nordisk, & Dexcom lead with revolutionary treatments
The Relative Strength (RS) Rating for DexCom stock entered a new percentile Monday, with a rise from 80 to 83.
These healthcare companies' target markets substantially overlap.